Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer

NAPOLI-1 (NCT01494506) was a phase III study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy. This post hoc analysis of NAPOLI-1 aimed to develop a predic...

Full description

Bibliographic Details
Main Authors: Li-Tzong Chen, Teresa Macarulla, Jean-Frédéric Blanc, Beloo Mirakhur, Floris A. de Jong, Bruce Belanger, Tanios Bekaii-Saab, Jens T. Siveke
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
liposomal irinotecan
NAPOLI-1
nomogram
pancreatic cancer
survival outcomes
Online Access:https://www.mdpi.com/2072-6694/11/8/1068

Internet

https://www.mdpi.com/2072-6694/11/8/1068

Similar Items